Combination of Oncolytic Measles Virus Armed With BNiP3, a Pro-apoptotic Gene and Paclitaxel Induces Breast Cancer Cell Death
Breast cancer is one of the major causes of cancer related mortality in women worldwide. Limitations of conventional anti-cancer therapies such as severe systemic side effects, narrow therapeutic index, non-specificity, and non-availability of drugs for all types of cancers has resulted in the devel...
Main Authors: | Geetanjali Lal, Maitreyi S. Rajala |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-01-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fonc.2018.00676/full |
Similar Items
-
Measles to the Rescue: A Review of Oncolytic Measles Virus
by: Sarah Aref, et al.
Published: (2016-10-01) -
Measles Virus as an Oncolytic Immunotherapy
by: Christine E. Engeland, et al.
Published: (2021-02-01) -
MECHANISMS AND CLINICAL EFFECTS OF DRUGS BASED ON ONCOLYTIC ADENOVIRUSES, HERPES VIRUSES, REOVIRUSES AND MEASLES VIRUS
by: A. P. Cherniakova, et al.
Published: (2020-12-01) -
A Combined Ultrafiltration/Diafiltration Process for the Purification of Oncolytic Measles Virus
by: Daniel Loewe, et al.
Published: (2022-01-01) -
Oncolytic Measles Virus Encoding MicroRNA for Targeted RNA Interference
by: Sophie C. Anker, et al.
Published: (2023-01-01)